Parkwalk Newsletter - Happy New Year
 
pw_logo_header
Happy New Year from Parkwalk
 
pw_newsletter_dna
 
Sector

Dear , 

Happy New Year.

2014 was an interesting year for UK University spin-outs as an asset class. Over $500m was raised in the UK last year by four fund managers and institutions, taking their listed valuations to over $4bn. University spin-outs becoming mainstream?

In the sector, highlights included IP Group raising $165m at nearly 2 times NAV; Allied Minds listing in London at a $670m valuation (at potentially 3 or 4 times NAV); Imperial Innovations raising $250m at nearly twice NAV; and Mercia raising $110m.  

These fund raises were backed by the likes of Woodford, Invesco Perpetual, Landsdowne and Baillie Gifford and this new money should make for better funded spin-outs at all stages, giving them higher chances of success.

 
 
Stage

As the largest EIS investor in this sector, generally co-investing alongside these institutions, Parkwalk made over 20 new or follow-on investments in 2014 and doubled our assets under management.

We achieved a near 10 times exit after just three years in Tracsis and a near 5 times exit in just under four years from Xeros. These exits mean Parkwalk UK Tech Funds I & II have both returned, in cash, more to investors than the total cost of their subscriptions into each Fund.

Funds I-II are currently valued at 2.60x cost including tax reliefs and fees (our Funds that are past the three-year minimum holding period for EIS).

Also in 2014 the University of Oxford Isis Fund I and University of Cambridge Enterprise Fund III were both over-subscribed, and Fund V and the Opportunities EIS Fund both raised record amounts.

The portfolio has grown to 34 companies and we have a robust deal flow for 2015.

So interestingly, whilst large institutions appear prepared to invest in this space at or above 2 times NAV, Parkwalk investors can participate in the same asset class through the Parkwalk EIS Funds at a 30% discount to NAV and CGT-free.
More detail can be seen on our website at www.parkwalkadvisors.com.

 

We would like to thank all our investors, colleagues and friends for their support in 2014 and wish you a healthy, happy and prosperous 2015.

 
 
 
 
 

Important Information

This financial promotion is issued by Parkwalk Advisors Limited (Parkwalk), which is authorised and regulated by the Financial Conduct Authority.  Investments referred to in this newsletter are not suitable for all investors.  Interested parties are strongly recommended to seek specialist financial and tax advice before investing in any Parkwalk product.  Capital is at risk and investors may not get back the full amount invested. Tax treatment depends on the individual circumstances of each investor and may be subject to change. Past performance is not a reliable indicator of future results, and the value of investments may go down as well as up. Projections and forecasts are also not a reliable indicator of future performance. Investments in small and unquoted companies carry a higher risk than many other forms of investment. Any investment in a Parkwalk product must only be made on the basis of the terms of the full Information Memorandum. Parkwalk is not able to provide advice as to the suitability of investing in a Parkwalk product.